Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease

Authors not listed

Medical University of Graz · 2016

Abstract

In this explorative longitudinal study 50 patients with Alzheimer's disease (AD) and 50 age-matched control subjects will be recruited for their 2 years follow-ups and undergo extensive cognitive testing and quantitative 3 Tesla magnetic resonance imaging (MRI). Regional differences of susceptibility and R2\* relaxation rates in deep gray matter and the neocortex will be evaluated in AD patients and controls and related to the patients´ cognitive status at baseline.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2016). Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease. <em>Medical University of Graz</em>. https://clinicaltrials.gov/study/NCT02752750
Vancouver
Anonymous. Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease. Medical University of Graz. 2016.
BibTeX
@misc{anon2016Longit, title = {Longitudinal Quantitative Susceptibility Mapping (QSM) in Alzheimer 's Disease}, author = {Anonymous}, journal = {Medical University of Graz}, year = {2016}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings